Zynerba Pharmaceuticals Announces Top Line Results from Pivotal CONNECT-FX Trial of Zygel™ (CBD Gel) in Fragile X Syndrome Nasdaq:ZYNE

Media coverage

• Title	Zynerba Pharmaceuticals Announces Top Line Results from Pivotal CONNECT-FX Trial of Zygel™ (CBD Gel) in Fragile X Syndrome Nasdaq:ZYNE
  Media name/outlet	Global English (Middle East and North Africa Financial Network)
  Country/Territory	Jordan
  Date	06/30/20
  Persons	William Roberts

• Title	Zynerba Pharmaceuticals Announces Top Line Results from Pivotal CONNECT-FX Trial of Zygel™ (CBD Gel) in Fragile X Syndrome
  Media name/outlet	Biotechgate
  Country/Territory	Switzerland
  Date	06/30/20
  URL	www.biotechgate.com/gate/v3/news_details.php?news_id=206775&page_id=?next=1
  Persons	William Roberts